Celebrating 50 years of Service. 1961 - 2011
MESSAGE FROM THE EphMRA
Happy New Year from all at
Of course, 2011 is not just any year…2011
marks EphMRA’s half-century: 50 exciting years of growth and
evolution! When EphMRA first came into being, market
research was in its infancy. Now it plays a critical role in
guiding companies’ tactical and strategic decision-making. As the
role of market research has changed, so too has the role of EphMRA.
Today we exist to help equip healthcare market researchers to be
highly valued partners to their businesses. When I look at the
range of initiatives both in place and on the horizon, I have no
doubt that EphMRA will spend the next fifty years continuing to do
As we celebrate our anniversary and all
that has been achieved, I would like to make two very important
toasts; firstly, to all those who have given their time and
expertise over the years to make EphMRA what it is today; and
secondly to you, our members, for your continued support – without
which we would not be able to provide the services we do.
So once again, from all at EphMRA, happy
New Year, happy anniversary, and thank you!
Best regards, Rob
Haynes, President of EphMRA
HOW DID IT ALL BEGIN?
In the 1950’s, the pharmaceutical industry
grew rapidly – thanks to the introduction of many new and unique
products designed for the relief of human and animal suffering. As
a result, however, the costs of research escalated exponentially.
At the same time, legislation and controls were introduced in many
countries at an ever-increasing rate.
For research-based pharmaceutical companies,
continued viability and prosperity became increasingly dependent on
the successful introduction and acceptance of their products in
countries throughout the world.
With the growing need for – and emphasis on –
a multinational outlook regarding product research and marketing,
there was a common requirement for reliable and comparable
information about these different countries.
In order to explore the obstacles to achieving
comparable information on a multinational basis, and to design
methods of overcoming them, representatives of fourteen
research-orientated European-based pharmaceutical companies met in
Geneva on May 5th 1961.
The result was the foundation of the European
Pharmaceutical Market Research Association (EphMRA).
1951-2011: THE KEY
Fifty years on, EphMRA now has members
worldwide and is responsible for a wide range of initiatives and
services that us to help achieve our vision: ‘‘creating excellence
in professional standards and practices to enable healthcare market
researchers to become highly valued business partners’.
Here just some of the ways in which EphMRA
supports members and, by extension, the industry today:
Bringing Clarity &
EphMRA’s Anatomical Classification of
Products (ACP) enables the industry to view the market in a
systematic and uniform manner. Used across the healthcare industry,
this system classifies all products in all therapeutic categories
worldwide – over 300,000 – and is continually updated to meet
market changes. The robustness of the ACP is evidenced by the fact
that it forms the architecture of virtually all pharmaceutical
As the international standard-bearer for
healthcare market research, EphMRA works to ensure that market
research is reliable, robust and ethical. Our latest EphMRA Code of
Conduct, released in 2009, is specific to the healthcare industry
and covers all legal, ethical and data protection issues – in line
with both international and local country codes. A ‘living
document’, the Code is continually updated to meet the industry’s
changing needs and includes a Code Enquiry Service for members.
EphMRA’s active Committees – including Data
& Systems, Syndicated Data, Primary Research Methods &
Training and New Form Codes – allow healthcare companies and their
suppliers to work together to raise standards and develop new
methods and systems for the benefit of all. All six of EphMRA’s
committees (including the Classification Committee and the
Foundation Committee) harness members’ collective knowledge for
investment in the industry’s future.
Providing Data &
EphMRA is also a key source of data,
information & guidance on industry-critical issues. Our
Foundation Committee was established to support and fund original
projects in the international healthcare market research and
business intelligence fields, and its outputs offer members
incisive information and knowledge on key issues – the BRIC
physician internet access survey, due this month, being just one.
In addition, EphMRA products publications such as the EphMRA
Lexicon and member resources like the forthcoming repository of
free-to-access high quality secondary data.
Training the Industry
Widely praised in a recent member survey, the
EphMRA training programme includes everything from research and
business skills to healthcare leadership skills. Delivered both
face-to-face and online, training is objective, structured and
flexible, and covers everything from basic introduction to advanced
skills. Perhaps most importantly, EphMRA’s training programme
creates a recognised and respected career development path that
helps attract and retain talent within the healthcare market
Sharing Knowledge & Opening
Finally, as per our founding principles,
EphMRA believes that knowledge sharing and communication offer
enormous benefits for individuals and member companies – both for
stimulating innovation and for overcoming common issues. EphMRA
opens the channels of communication both formally via industry
conferences and scheduled communications, and informally through
the facilitation of peer-to-peer and supplier interaction at
HOW ARE WE CELEBRATING?
The past 50 years have given EphMRA much to
celebrate! We will be toasting our achievements at this year’s
annual conference: ‘Stepping it Up’, Basel, 27-29 June.
Registration opens in January so watch this
HAVE YOUR SAY
What do you think has been EphMRA’s
most important contribution? How could we make the next 50 years
Tell us by emailing
email@example.com and we’ll publish some of your answers
in the next issue of EphMRA News.